The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

Here are four more updates: Influenza activity remained elevated but has been declining for four consecutive weeks. Flu-related emergency department visits remain moderate, and test positivity is at ...

The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.

Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...

The Food and Drug Administration has issued its flu vaccine recommendations for 2025 into 2026. The FDA says that vaccines for the upcoming respiratory virus season should be trivalent. That means to ...

After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the upcoming 2025-26 season.

As outbreaks for several diseases are being monitored across the U.S., state DPH Commissioner Robbie Goldstein has an update ...

Matt Caldwell, left, a Lubbock Fire Department official, administers a measles, mumps and rubella vaccine to Clair May, 61, ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Q4 2024 Earnings Call Transcript March 6, 2025 Arcturus Therapeutics Holdings Inc. misses on earnings expectations. Reported ...

This week, the Food and Drug Administration — now with vaccine skeptic Robert F. Kennedy Jr. at the helm — unexpectedly and ...

In adults 65 years and older, the group with the greatest risk of hospitalization and death, flu vaccination rates dropped from 52% in 2019-20 to 43% in 2024-25. Lower vaccination rates mean a greater ...